Assessing XPEL (XPEL) Valuation As Paint Protection Film Growth And Awareness Campaigns Draw Attention
XPEL, Inc. XPEL | 0.00 |
Recent reports highlight XPEL (XPEL) as a significant participant in the paint protection films market, which is projected to expand sharply by 2030. At the same time, its Skin Cancer Awareness Month promotions have drawn fresh attention to the stock.
Despite upbeat first quarter results and fresh interest from its Skin Cancer Awareness Month campaign, XPEL’s share price has been under pressure recently. Its 30 day share price return is down 12.34% and its year to date share price return is down 17.42%. The 1 year total shareholder return of 10.67% sits against a 3 year total shareholder return down 44.35% and a 5 year total shareholder return down 46.06%, which suggests momentum has been fading over the longer term even as recent news has kept the story in focus.
If XPEL’s recent moves have you thinking about where growth-focused capital could go next, it may be worth sizing up 18 top founder-led companies
With recent returns under pressure but first quarter earnings, analyst targets and some intrinsic value models pointing to higher figures than today’s US$41.49 share price, investors may be wondering if XPEL is a mispriced growth story or if the market is already crediting its next chapter.
Most Popular Narrative: 25% Undervalued
XPEL’s most followed valuation narrative places fair value at about $55.33, compared with the latest close at $41.49, putting a spotlight on the gap between model and market.
Expansion into emerging and international markets (e.g., Thailand, Japan, China, Brazil, Europe, India, Middle East) is well underway, with further direct distribution efforts and M&A planned, which broadens XPEL's addressable market and diversifies revenue streams, supporting accelerated revenue growth and reducing regional concentration risk over time.
Curious what sits behind that valuation gap? The narrative leans heavily on expectations for compounding revenue, rising profitability and a future earnings multiple that needs to hold up.
Result: Fair Value of $55.33 (UNDERVALUED)
However, this depends on competitive pressure from lower cost rivals and the risk that more factory installed protection films could eat into XPEL’s aftermarket demand.
Another Angle On Valuation
While the SWS DCF model points to XPEL trading at a steep discount to an estimated future cash flow value of $149.73, the current P/E of 21.6x sits slightly above the US Auto Components industry at 19.1x and just below a fair ratio of 23.4x. This raises a simple question: is the market being cautious or just early?
Next Steps
With mixed signals across valuation models and market pricing, it helps to look under the hood yourself and decide whether the optimism fits your view. If you want a quick way to see what investors are currently excited about, start by reviewing the 4 key rewards
Looking for more investment ideas?
If XPEL has sharpened your focus, do not stop here. Use the Simply Wall St screener to line up your next set of thoughtful stock ideas.
- Target reliable income streams by reviewing 14 dividend fortresses that aim to combine meaningful yield with business resilience.
- Spot potential mispricings by scanning 51 high quality undervalued stocks where quality fundamentals and current prices appear out of sync.
- Strengthen your watchlist with 66 resilient stocks with low risk scores that score well on balance sheet strength and volatility measures.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
